Skip to the page

Data / Private funds / Venture capital funds / Gaingels Gen1e Lifesciences LLC

Gaingels Gen1e Lifesciences LLC: venture capital fund

Read from the Form ADV filings through October 31, 2026. Source: the SEC's Form ADV Part 1 data files, Schedule D Section 7.B.(1).

Gaingels Gen1e Lifesciences LLC is a venture capital fund managed by Gaingels Ventures LLC, an adviser in Burlington, Vermont. Its adviser reported $190,372 in gross assets, 10 beneficial owners and a minimum investment of $1,000 in the Form ADV filed March 31, 2026. It is organized in Vermont, United States.

The full lists. Venture capital funds reported in Form ADV: 46,659 rows, $546.59. Private funds reported in Form ADV: 126,391 rows, $1,343.91. $10 of credit on sign-up, no card. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (adviser city, adviser state, percent owned by non US persons, auditor, administrator, custodians and 2 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.

Get the first 200 rows free
Get an API key

The request: Watch Gaingels Gen1e Lifesciences LLC (SEC private fund ID 805-6339297533): each new Form ADV filing, with its gross assets, owners and service providers.

SpecStream is the live web data engine for teams and agents. It reads the SEC's Form ADV filings every month, and this page is that reading, keyed on the SEC's private fund ID. Ask for the funds you track by type, size, adviser or service provider, and new funds and changed filings arrive in your sheet, CRM, Slack or agent as the SEC publishes them.

Fund type
Venture capital fund
SEC private fund ID
805-6339297533
Adviser
Gaingels Ventures LLC
Adviser CRD number
317099
Adviser's main office
Burlington, Vermont
Gross asset value
$190,372
Beneficial owners
10
Minimum investment
$1,000
Owned by non US persons
0%
Owned by the adviser and related persons
1%
Owned by funds of funds
55%
Fund of funds
No
Organized in
Vermont, United States
Investment Company Act exclusion
section 3(c)(1)
Annual audit
No
Form D file number
021-470809
Form ADV filed
March 31, 2026
Source
The adviser's Form ADV on the SEC's adviser site

Service providers

The firms the adviser names for this fund in Form ADV Schedule D, Section 7.B.(1).

FirmRoleOffice
Silicon Valley BankCustodianSanta Clara, California

Other private funds of Gaingels Ventures LLC

733 other funds in the same Form ADV; the 25 largest are shown.

FundTypeGross assetsOwners
Gaingels Limbic AI LLCVenture capital fund$25.1 million24
Gaingels Beyondtrucks LLCVenture capital fund$10.5 million7
Gaingels Spark II LLCVenture capital fund$7.5 million202
Gaingels Holdings Core 2023 LLCVenture capital fund$7.2 million60
Gaingels AI Fund I LLCVenture capital fund$7 million177
Gaingels Axiom Space 2022 LLCVenture capital fund$5.8 million48
Gaingels Cart LLCVenture capital fund$5.7 million15
Gaingels Spark III LLCVenture capital fund$4.5 million163
Gaingels Rejuveron LLCVenture capital fund$4.2 million17
Gaingels Copper 2022 LLCVenture capital fund$4 million30
Gaingels Perch LLCVenture capital fund$3.9 million244
Gaingels Early Stage Fund I LLCVenture capital fund$3.5 million103
Gaingels Predictionstrike LLCVenture capital fund$3 million18
Gaingels Epirus LLCVenture capital fund$2.6 million32
Gaingels Atmos LLCVenture capital fund$2.5 million11
Gaingels Mythical 2025 LLCVenture capital fund$2.5 million34
Gaingels Impulse LLCVenture capital fund$2.5 million15
Gaingels Biostate AI LLCVenture capital fund$2.4 million10
Gaingels Curebase LLCVenture capital fund$2.3 million34
Gaingels Night Street Games LLCVenture capital fund$2.2 million11
Gaingels Superluminal LLCVenture capital fund$2.2 million34
Gaingels Healthcare I LLCVenture capital fund$2.1 million38
Gaingels Exostellar LLCVenture capital fund$1.9 million13
Gaingels Humane LLCVenture capital fund$1.8 million58
Gaingels Neurophos 2025 LLCVenture capital fund$1.8 million63

Also on SpecStream

Public data published by the US Securities and Exchange Commission (US government work). Advisers report these values themselves in Form ADV Schedule D, Section 7.B.(1), and neither the SEC nor the states approve or guarantee them. Gross asset value is the fund's value as the adviser reported it in its latest Form ADV filing, which can be months old. A fund that two advisers report shows under the adviser with the newer filing. Service providers are named as the adviser wrote them; a name that could be a person's is left out. This page uses SEC data and is not endorsed or certified by the SEC. Free to quote with credit and a link. Copying in bulk needs a data licence. Spot a wrong value? Write to [email protected] with the link to this page.

$10 of credit on sign-up, no card.

Get the first 200 rows free

Business lists in the United States

More public records